{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:26:16Z","timestamp":1793579176681,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:00:00Z","timestamp":1793577600000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AstraZeneca Singapore Pte Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00533-2","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:07:53Z","timestamp":1783480073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of targeted COPD case-finding with the PUMA questionnaire followed by spirometry among ever-smokers in Singapore"],"prefix":"10.1038","volume":"36","author":[{"given":"Irene Li Peng","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky Mengqi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Sing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geak Poh","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Manski-Nankervis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshar","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"533_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","volume":"10","author":"D Adeloye","year":"2022","unstructured":"Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 10, 447\u2013458 (2022).","journal-title":"Lancet Respir Med."},{"key":"533_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","volume":"11","author":"LM Fabbri","year":"2023","unstructured":"Fabbri, L. M. et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med. 11, 1020\u20131034 (2023).","journal-title":"Lancet Respir Med."},{"key":"533_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1440-1843.2011.02073.x","volume":"17","author":"W-SK Teo","year":"2012","unstructured":"Teo, W.-S. K. et al. Economic burden of chronic obstructive pulmonary disease. Respirology 17, 120\u2013126 (2012).","journal-title":"Respirology"},{"key":"533_CR4","unstructured":"Ministry of Health Singapore. Principal Causes of Death. 2024. Accessed September 22, 2025. https:\/\/www.moh.gov.sg\/others\/resources-and-statistics\/principal-causes-of-death\/"},{"key":"533_CR5","doi-asserted-by":"publisher","unstructured":"Qin VM, et al. Predictive performance of the PUMA questionnaire as an opportunistic COPD case-finding tool in Singapore primary care. NPJ Prim Care Respir Med. Published online April 14, 2026. https:\/\/doi.org\/10.1038\/s41533-026-00510-9","DOI":"10.1038\/s41533-026-00510-9"},{"key":"533_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/15412555.2013.766683","volume":"10","author":"MJ Joo","year":"2013","unstructured":"Joo, M. J., Sharp, L. K., Au, D. H., Lee, T. A. & Fitzgibbon, M. L. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD 10, 444\u2013449 (2013).","journal-title":"COPD"},{"key":"533_CR7","first-page":"201","volume":"34","author":"JAE Walters","year":"2005","unstructured":"Walters, J. A. E. et al. Barriers to the use of spirometry in general practice. Aust Fam Physician 34, 201\u2013203 (2005).","journal-title":"Aust Fam Physician"},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"200350","DOI":"10.1183\/16000617.0350-2020","volume":"30","author":"E Schnieders","year":"2021","unstructured":"Schnieders, E. et al. Performance of alternative COPD case-finding tools: a systematic review and meta-analysis. European Respiratory Review 30, 200350 (2021).","journal-title":"European Respiratory Review"},{"key":"533_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-24797-4","volume":"25","author":"C Song","year":"2025","unstructured":"Song, C. et al. Cost-effectiveness of screening for chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Public Health 25, 3779 (2025).","journal-title":"BMC Public Health"},{"key":"533_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/resp.12834","volume":"21","author":"MV L\u00f3pez Varela","year":"2016","unstructured":"L\u00f3pez Varela, M. V. et al. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study. Respirology 21, 1227\u20131234 (2016).","journal-title":"Respirology"},{"key":"533_CR11","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2147\/COPD.S206250","volume":"14","author":"MV Lopez Varela","year":"2019","unstructured":"Lopez Varela, M. V. et al. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population. Int J Chron Obstruct Pulmon Dis. 14, 1901\u20131911 (2019).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"533_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41533-021-00233-z","volume":"31","author":"S Qu","year":"2021","unstructured":"Qu, S. et al. Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China. NPJ Prim Care Respir Med. 31, 28 (2021).","journal-title":"NPJ Prim Care Respir Med."},{"key":"533_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/thoraxjnl-2018-212148","volume":"74","author":"T Lambe","year":"2019","unstructured":"Lambe, T. et al. Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care. Thorax 74, 730\u2013739 (2019).","journal-title":"Thorax"},{"key":"533_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","volume":"207","author":"A Agust\u00ed","year":"2023","unstructured":"Agust\u00ed, A. et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 207, 819\u2013837 (2023).","journal-title":"Am J Respir Crit Care Med."},{"key":"533_CR15","doi-asserted-by":"publisher","unstructured":"Waeijen-Smit K, et al. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients. ERJ Open Res. 2024;10. https:\/\/doi.org\/10.1183\/23120541.00838-2023","DOI":"10.1183\/23120541.00838-2023"},{"key":"533_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","volume":"67","author":"S Suissa","year":"2012","unstructured":"Suissa, S., Dell\u2019Aniello, S. & Ernst, P. Long-term natural history of chronic obstructive pulmonary disease: Severe exacerbations and mortality. Thorax 67, 957\u2013963 (2012).","journal-title":"Thorax"},{"key":"533_CR17","unstructured":"Ministry of Health Singapore. National Population Health Survey 2023. 2024."},{"key":"533_CR18","doi-asserted-by":"publisher","first-page":"1190885","DOI":"10.3389\/fmed.2023.1190885","volume":"10","author":"C Chung","year":"2023","unstructured":"Chung, C., Lee, K. N., Han, K., Shin, D. W. & Lee, S. W. Effect of smoking on the development of chronic obstructive pulmonary disease in young individuals: a nationwide cohort study. Front Med. (Lausanne) 10, 1190885 (2023).","journal-title":"Front Med. (Lausanne)"},{"key":"533_CR19","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD) Results - 2023. Accessed April 22, 2026. https:\/\/vizhub.healthdata.org\/gbd-results\/"},{"key":"533_CR20","unstructured":"Department of Statistics Singapore. Complete Life Tables for Singapore Resident Population, 2023-2024. 2025."},{"key":"533_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05033-w","volume":"15","author":"H Ogata","year":"2025","unstructured":"Ogata, H. et al. Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study. Sci. Rep. 15, 19097 (2025).","journal-title":"Sci. Rep."},{"key":"533_CR22","doi-asserted-by":"publisher","first-page":"e1001631","DOI":"10.1371\/journal.pmed.1001631","volume":"11","author":"W Zheng","year":"2014","unstructured":"Zheng, W. et al. Burden of total and cause-specific mortality related to tobacco smoking among adults aged \u226545 years in Asia: A pooled analysis of 21 cohorts. PLoS Med. 11, e1001631 (2014).","journal-title":"PLoS Med."},{"key":"533_CR23","doi-asserted-by":"publisher","first-page":"e1002958","DOI":"10.1371\/journal.pmed.1002958","volume":"16","author":"HW Lee","year":"2019","unstructured":"Lee, H. W., Park, J., Jo, J., Jang, E. J. & Lee, C. H. Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis. PLoS Med. 16, e1002958 (2019).","journal-title":"PLoS Med."},{"key":"533_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","volume":"5","author":"MK Han","year":"2017","unstructured":"Han, M. K. et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 5, 619\u2013626 (2017).","journal-title":"Lancet Respir Med."},{"key":"533_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.15585\/mmwr.mm7329a1","volume":"73","author":"B VanFrank","year":"2024","unstructured":"VanFrank, B. et al. Adult Smoking Cessation \u2014 United States, 2022. MMWR Morb. Mortal Wkly Rep. 73, 633\u2013641 (2024).","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"533_CR26","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/136422","volume":"19","author":"B Saylan","year":"2021","unstructured":"Saylan, B., Baslilar, S. & Kartaloglu, Z. Comparative assessment of outcomes of smoking cessation therapies and role of free medications in successful long-term abstinence. Tob. Induc. Dis. 19, 51 (2021).","journal-title":"Tob. Induc. Dis."},{"key":"533_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.47102\/annals-acadmedsg.V41N5p230","volume":"41","author":"KK Kng","year":"2012","unstructured":"Kng, K. K., Lauw, X. T., Tan, A. S. L. & Earnest, A. Effectiveness of smoking cessation services in Tan Tock Seng Hospital, Singapore. Ann. Acad. Med. Singap. 41, 230\u2013232 (2012).","journal-title":"Ann. Acad. Med. Singap."},{"key":"533_CR28","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.2147\/COPD.S147070","volume":"12","author":"KP Chan","year":"2017","unstructured":"Chan, K. P. et al. Adherence to a COPD treatment guideline among patients in Hong Kong. International Journal of COPD 12, 3371\u20133379 (2017).","journal-title":"International Journal of COPD"},{"key":"533_CR29","unstructured":"Agency for Care Effectiveness. Drug and Vaccine Evaluation Methods and Process Guide. 2025. Accessed October 2, 2025. https:\/\/isomer-user-content.by.gov.sg\/68\/7985253c-dc1a-4d8f-a25b-778b8c431049\/ACE%20ACG%20Methods%20and%20Processes%20Manual%20May2025%20v1.pdf"},{"key":"533_CR30","unstructured":"Ministry of Health Singapore. HealthHub: I Quit Programme. Accessed April 12, 2026. https:\/\/www.healthhub.sg\/programmes\/iquit"},{"key":"533_CR31","unstructured":"Agency for Integrated Care. Healthier SG Whitelist. Primary Care Pages. Accessed December 19, 2025. https:\/\/www.primarycarepages.sg\/healthier-sg\/subsidised-drugs\/whitelist"},{"key":"533_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.11622\/smedj.2018022","volume":"59","author":"A Tee","year":"2018","unstructured":"Tee, A., Chow, W. L., Burke, C. & Guruprasad, B. Cost-effectiveness of indacaterol\/glycopyrronium in comparison with salmeterol\/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: A LANTERN population analysis from Singapore. Singapore Med. J. 59, 383\u2013389 (2018).","journal-title":"Singapore Med. J."},{"key":"533_CR33","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.vhri.2020.07.378","volume":"22","author":"A Viswambaram","year":"2020","unstructured":"Viswambaram, A., Wee, Y. R. & LIM, S. PMU20 is there an implicit willingness-to-pay threshold in Singapore?. Value Health Reg. Issues 22, S72 (2020).","journal-title":"Value Health Reg. Issues"},{"key":"533_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02204-0","volume":"20","author":"D Husereau","year":"2022","unstructured":"Husereau, D. et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 20, 23 (2022).","journal-title":"BMC Med."},{"key":"533_CR35","doi-asserted-by":"crossref","unstructured":"Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. John Wiley and Sons Ltd. 2014;2014 CD009285.","DOI":"10.1002\/14651858.CD009285.pub3"},{"key":"533_CR36","unstructured":"Ministry of Health Singapore. Chronic Disease Management Programme (CDMP). January 21, 2021. Accessed December 29, 2025. https:\/\/www.moh.gov.sg\/others\/resources-and-statistics\/chronic-disease-management-programme-cdmp\/"},{"key":"533_CR37","unstructured":"Ministry of Health Singapore. Community Health Assist Scheme (CHAS). September 1, 2025. Accessed December 30, 2025. https:\/\/www.moh.gov.sg\/managing-expenses\/schemes-and-subsidies\/chas\/"},{"key":"533_CR38","doi-asserted-by":"publisher","first-page":"1801448","DOI":"10.1183\/13993003.01448-2018","volume":"52","author":"JB Soriano","year":"2018","unstructured":"Soriano, J. B., Polverino, F. & Cosio, B. G. What is early COPD and why is it important?. European Respiratory Journal 52, 1801448 (2018).","journal-title":"European Respiratory Journal"},{"key":"533_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0272989X251395096","volume":"46","author":"D Patil","year":"2026","unstructured":"Patil, D., Liljas, B., Neumann, P. J. & Li, M. When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013\u20132023. Medical Decision Making 46, 334\u2013342 (2026).","journal-title":"Medical Decision Making"},{"key":"533_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13143-4","volume":"25","author":"HY Tan","year":"2025","unstructured":"Tan, H. Y., Tan, J. K., Lam, L. T., Tan, D. H. & Chua, Y. X. Insights into Singapore\u2019s national strategy for primary care reform: physician attitudes, facilitators and barriers to healthier SG. BMC Health Serv. Res. 25, 1021 (2025).","journal-title":"BMC Health Serv. Res."},{"key":"533_CR41","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/COPD.S250720","volume":"ume 15","author":"M Llord\u00e9s","year":"2020","unstructured":"Llord\u00e9s, M. et al. Fixed ratio versus lower limit of normality for diagnosing COPD in primary care: long-term follow-up of EGARPOC study. Int. J. Chron. Obstruct Pulmon Dis. ume 15, 1403\u20131413 (2020).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"533_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/COPD.S13826","volume":"5","author":"M Hoogendoorn","year":"2010","unstructured":"Hoogendoorn, M., Feenstra, T. L., Hoogenveen, R. T., Al, M. & van M\u00f6lken, M. R. Association between lung function and exacerbation frequency in patients with COPD. Int. J. Chron. Obstruct Pulmon Dis. 5, 435\u2013444 (2010).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"533_CR43","volume":"46","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study. Lancet Reg. Health West Pac. 46, 101065 (2024).","journal-title":"Lancet Reg. Health West Pac."},{"key":"533_CR44","doi-asserted-by":"publisher","unstructured":"Martinez, F. J. et al. Benefits of glycopyrrolate\/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: A pooled analysis of the PINNACLE studies. Respir Res. 21. https:\/\/doi.org\/10.1186\/s12931-020-01388-y (2020).","DOI":"10.1186\/s12931-020-01388-y"},{"key":"533_CR45","doi-asserted-by":"publisher","unstructured":"Juang, Y. R. et al. Projecting the 20-year healthcare resource burden of asthma and COPD multimorbidity: insights from Singapore for integrated chronic respiratory care in South-East Asia. npj Prim. Care Respir. Med. https:\/\/doi.org\/10.13140\/RG.2.2.25501.17122 (2026).","DOI":"10.13140\/RG.2.2.25501.17122"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00533-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:26:39Z","timestamp":1793575599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00533-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00533-2","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"75"}}